Biotech britannica che sviluppa terapie mirate ai mitocondri per ALS e Parkinson.
Funding history
Date
Round
Amount
Sep 2025
Series B
NRG Therapeutics raised £50 million in a Series B led by SV Health's Dementia Discovery Fund to bring its mitochondrial candidate NRG5051 into the clinic.
$63.5M
Investors
Brandon CapitalBritish Business BankCriteria Bio VenturesM VenturesNovartis Venture FundOmega FundsSV Health Investors Dementia Discovery Fund